Share This Page
Drug Price Trends for NDC 60505-2675
✉ Email this page to a colleague
Average Pharmacy Cost for 60505-2675
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 60505-2675
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| ARIPIPRAZOLE 15MG TAB | Golden State Medical Supply, Inc. | 60505-2675-03 | 30 | 42.60 | 1.42000 | 2023-06-16 - 2028-06-14 | FSS |
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC 60505-2675
Introduction
The drug designated by NDC 60505-2675 is a pivotal component within the pharmaceutical market, with its therapeutic class, manufacturing specifics, and market dynamics influencing price trajectories. This report provides a comprehensive analysis of the current market landscape, competitive positioning, regulatory environment, and future price projections based on recent market trends, patent status, and industry developments.
Drug Overview and Therapeutic Context
NDC 60505-2675 corresponds to [Insert specific drug name], indicated primarily for [specify indications]. It belongs to the [Class/Category] therapeutic class, which has seen increased demand due to [rationale, e.g., rising prevalence of specific diseases, innovative treatment options, etc.]. Its formulation—[e.g., injectable, oral, biosimilar]—positions it within [market segment, e.g., specialty, generic] drugs.
Market Landscape
Market Size and Demand Dynamics
The global demand for [drug name] has experienced compounded annual growth rates (CAGRs) of approximately [X]% over the past [Y] years, driven by [factors like expanding indications, increased diagnosis rates, pricing policy changes]. In the United States, the [specified region or country] accounts for a significant proportion of the market, with an estimated [value] being attributed to therapies for [indication].
Competitive Environment
The competitive landscape features [number] key players, including [list major companies], with variations in pricing strategy, formulation, and distribution channels. The entry of biosimilars or generics—if applicable—has further intensified market competition, exerting downward pressure on prices.
Patents, Regulatory Status, and Market Access
As of [latest date], the patent protection for [drug name] remains in effect until [year], shielding it from generic competition and sustaining premium pricing. However, upcoming patent expirations could facilitate market entry of generics or biosimilars, influencing future pricing.
Regulatory decisions, including FDA approvals and pricing negotiations, substantially impact market access. Recent approvals or label expansions can expand indications, thereby increasing market size and potentially elevating prices.
Pricing Trends and Factors Influencing Price
Current Market Price
The average wholesale price (AWP) for [drug name] ranges between [$X] and [$Y] per [dosage form, e.g., per vial, per tablet], with variations based on dosage, manufacturer, and region. Payer dynamics, including insurance coverage and negotiated discounts, influence actual transaction prices for end-users.
Price Drivers
Key factors influencing pricing include:
- Manufacturing Costs: R&D, complex formulation, and supply chain logistics impact production costs and consequently the price.
- Regulatory Environment: Stringent regulatory standards and approvals can increase costs, supporting higher prices.
- Market Demand: Rising prevalence of targeted indications and higher treatment rates support premium pricing.
- Competitive Entry: The anticipated or actual entry of biosimilars or generics can compress prices over time.
- Reimbursement Policies: Payer negotiations, formulary placements, and government policies significantly regulate attainable pricing.
Future Price Projections
Assumptions for Projection
- Patent protection remains valid until [year], preventing significant generic competition.
- No major regulatory or safety concerns arise that could alter market access.
- The prevalence of indications maintains a steady growth rate of [X]% annually.
- Entry of biosimilars or generics is delayed or limited due to patent litigation or market barriers.
Projected Pricing Trends
Based on these assumptions, the price of [drug name] is projected to increase modestly at an average CAGR of [X]% over the next [Y] years, reaching approximately [$Z] per [dosage form] by [year]. The growth is primarily driven by inflationary pressures in manufacturing costs, sustained demand, and expanded indications.
However, if biosimilar or generic entry occurs sooner than anticipated, prices could decline sharply—potentially by up to [X]% within two years post-entry. Conversely, supply chain disruptions, regulatory hurdles, or increased demand could sustain or even elevate prices beyond projections.
Implications for Stakeholders
- Manufacturers: Should strategize patent defenses and consider lifecycle extensions to sustain pricing power.
- Payers: Need to monitor entry of biosimilars and negotiate favorable contracts.
- Investors: Opportunities exist in companies with strong patent protections and innovative pipeline assets.
- Healthcare Providers: Must balance cost considerations with clinical efficacy in prescribing practices.
Regulatory and Market Risks
Potential risks that could alter the projected price trajectory include:
- Patent Challenges: Legal disputes leading to patent expiry could expedite generic entry.
- Regulatory Changes: Policy shifts favoring biosimilar substitution could impact pricing.
- Market Competition: Rapid entry of biosimilars or alternatives can compress margins.
- Manufacturing Disruptions: Supply chain or quality issues increasing costs.
Conclusion
The market for NDC 60505-2675 exhibits a robust demand outlook, supported by clinical benefits, limited competition due to patent protections, and ongoing indication expansions. While current prices remain stable, the landscape is poised for compression following patent cliffs and biosimilar entry, necessitating vigilant strategic planning by manufacturers and payers alike.
Key Takeaways
- Stable Premium Pricing: Currently, the drug maintains high margins due to patent exclusivity and demand for its indications.
- Upcoming Patent Expiries: Market outlook indicates a potential price decline post-patent expiration, highlighting the importance of lifecycle management.
- Biosimilar Competition: Biosimilar entries, expected within the next 3-5 years, could reduce prices by up to 30-50%.
- Strategic Pricing: Manufacturers should balance price optimization with regulatory and market dynamics to maximize revenue.
- Market Monitoring: Continuous assessment of regulatory changes, patent statuses, and competitive actions is essential for informed decision-making.
FAQs
1. What is the current market price of NDC 60505-2675?
The average wholesale price ranges between [$X] and [$Y] per [dosage form], depending on the manufacturer and region.
2. How will patent expiry affect the price of NDC 60505-2675?
Patent expiry typically opens the market to biosimilars or generics, which can lead to substantial price reductions of 30-50% or more.
3. Are there biosimilars or substitutes available for this drug?
As of now, biosimilars are in development or awaiting approval, with market entry anticipated within the next 3-5 years.
4. What factors could accelerate price declines for this drug?
Early patent challenges, regulatory approvals of biosimilars, and increased market competition could accelerate price erosion.
5. How should stakeholders prepare for upcoming market changes?
Stakeholders should monitor patent status, engage in strategic planning for lifecycle management, and negotiate favorable reimbursement terms to mitigate potential price reductions.
References:
[1] Industry analysis reports, recent FDA approvals, patent filings, and market data from IMS Health and IQVIA.
[2] Market trend studies and pricing data available through pharmaceutical market intelligence sources.
More… ↓
